Volume 27, Issue 2 (11-2024)
jha 2024, 27(2): 1-15 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mesgarpour_Amiri M, Shokri N, Abi B, Hosseini_Shokouh S J, Nasiri T, Hosseini_Shokouh S M. Factors related to the cost of treating inpatients with COVID-19 in a military treatment center in Tehran: lessons learned from the economics of treatment in a pandemic. jha 2024; 27 (2) :1-15
URL: http://jha.iums.ac.ir/article-1-4474-en.html
URL: http://jha.iums.ac.ir/article-1-4474-en.html
Mohammad Mesgarpour_Amiri1 
, Naeim Shokri2 , Behnam Abi1 , Seyyed Javad Hosseini_Shokouh3 , Taha Nasiri2 , Seyyed Morteza Hosseini_Shokouh 4
, Naeim Shokri2 , Behnam Abi1 , Seyyed Javad Hosseini_Shokouh3 , Taha Nasiri2 , Seyyed Morteza Hosseini_Shokouh 4
1- Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran
2- Faculty of Public Health and Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran
3- Dep. of Infectious Disease, School of Medicine, AJA University of Medical Sciences, Tehran
4- Faculty of Public Health and Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran ,hosainysh.morteza@gmail.com
2- Faculty of Public Health and Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran
3- Dep. of Infectious Disease, School of Medicine, AJA University of Medical Sciences, Tehran
4- Faculty of Public Health and Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran ,
Abstract: (136 Views)
Introduction: Understanding the hospital costs associated with COVID-19 and their impact on different populations helps develop a comprehensive approach to hospital preparedness, decision-making, and risk management. This study aimed to analyze the costs and identify factors associated with the direct treatment costs of hospitalized COVID-19 patients in a military hospital in Tehran.
Methods: This cross-sectional, descriptive-analytical economic evaluation study was conducted from February 20, 2020, to November 19, 2021, using a census of 28,997 hospitalized COVID-19 patients in a military hospital. Data analysis was performed using SPSS 26 and STATA 17 software, employing ordinary least squares regression and logistic regression.
Results: The total direct medical costs of treating the patients were 3,510,832,085,964 IRR (Iranian Rial), and the average treatment cost per patient was 121,049,964 IRR. Age, length of stay, place of residence, and comorbidities were significantly associated with treatment costs. The results showed that increasing age, length of stay, and the presence of other diseases had a significant positive correlation with treatment costs.
Conclusion: To reduce patient costs, healthcare policymakers should improve insurance coverage, hotel services, and pharmaceutical provision, and promote a culture of seeking medical care earlier. Other important measures include outpatient treatment instead of hospitalization, telehealth follow-up, reducing hospital length of stay, prioritizing the elderly in preventive programs such as screening and vaccination, and providing greater insurance support for COVID-19 patients with comorbidities and specific conditions
Methods: This cross-sectional, descriptive-analytical economic evaluation study was conducted from February 20, 2020, to November 19, 2021, using a census of 28,997 hospitalized COVID-19 patients in a military hospital. Data analysis was performed using SPSS 26 and STATA 17 software, employing ordinary least squares regression and logistic regression.
Results: The total direct medical costs of treating the patients were 3,510,832,085,964 IRR (Iranian Rial), and the average treatment cost per patient was 121,049,964 IRR. Age, length of stay, place of residence, and comorbidities were significantly associated with treatment costs. The results showed that increasing age, length of stay, and the presence of other diseases had a significant positive correlation with treatment costs.
Conclusion: To reduce patient costs, healthcare policymakers should improve insurance coverage, hotel services, and pharmaceutical provision, and promote a culture of seeking medical care earlier. Other important measures include outpatient treatment instead of hospitalization, telehealth follow-up, reducing hospital length of stay, prioritizing the elderly in preventive programs such as screening and vaccination, and providing greater insurance support for COVID-19 patients with comorbidities and specific conditions
Type of Study: Research |
Subject:
Health Economics
Received: 2024/06/25 | Accepted: 2024/09/20 | Published: 2024/12/15
Received: 2024/06/25 | Accepted: 2024/09/20 | Published: 2024/12/15
References
1. Maurice RL. Post-Covid-19: time to change our way of life for a better future. Epidemiologia. 2024 May 22;5(2):211-20. [DOI:10.3390/epidemiologia5020015]
2. Postma MJ, Chhatwal J. Covid-19 health economics: looking back and scoping the future. Value in Health. 2022 May 1;25(5):695-6. Available at: URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8979475/ [DOI:10.1016/j.jval.2022.03.008]
3. Popescu M, Ştefan OM, Ştefan M, Văleanu L, Tomescu D. ICU-associated costs during the fourth wave of the COVID-19 pandemic in a tertiary hospital in a low-vaccinated Eastern European Country. International journal of environmental research and public health. 2022 Feb 4;19(3):1-11. [DOI:10.3390/ijerph19031781]
4. Ashtari S, Vahedi M, Pourhoseingholi MA, Pourhoseingholi A, Safaee A, Moghimi-Dehkordi B, Zali MR. Estimation of average diagnosis and treatment costs of hepatitis C. Gastroenterology and Hepatology from Bed to Bench. 2012;5(3):139-45. Available at: URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC4017475/
5. Wang X, Shen M, Xiao Y, Rong L. Optimal control and cost-effectiveness analysis of a Zika virus infection model with comprehensive interventions. Applied Mathematics and Computation. 2019 Oct 15;359:165-85. [DOI:10.1016/j.padiff.2024.100754]
6. Bloom DE, Cadarette D, Ferranna M. The societal value of vaccination in the age of COVID-19. American Journal of Public Health. 2021 Jun;111(6):1049-54. [DOI:10.2105/AJPH.2020.306114]
7. Kapinos KA, Peters RM, Murphy RE, Hohmann SF, Podichetty A, Greenberg RS. Inpatient costs of treating patients with COVID-19. JAMA Network Open. 2024 Jan 2;7(1):e2350145:1-13. [DOI:10.1001/jamanetworkopen.2023.50145]
8. Rae M, Claxton G, Kurani N, McDermott D, Cox C. Potential costs of coronavirus treatment for people with employer coverage. Peterson Center on Healthcare and Kaiser Family Foundation. 2020 Mar 13;13. Available at: URL: https://www.healthsystemtracker.org/brief/potential-costs-of-coronavirus-treatment-for-people-with-employer-coverage/
9. Mojtabaeian SM, Monfared F. Diagnostic and treatment costs of patients diagnosed or suspected of COVID-19 disease in eastern Iran. Navid No. 2022 Aug 23;25(82):27-37. [In Persian]. Available at: URL: https://nnj.mums.ac.ir/article_21670_1051c8b137f97c254dd8f3b483de1439.pdf
10. Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L, Patterson BJ, Yektashenas B, Mesa-Frias M, Tronczynski K, Buyukkaramikli N. Economic burden of COVID-19: A systematic review. ClinicoEconomics and Outcomes Research. 2022 Apr 28:293-307. Available at: URL: https://www.tandfonline.com/doi/full/10.2147/CEOR.S338225 [DOI:10.2147/CEOR.S338225]
11. Seringa J, Pedreiras S, Freitas MJ, Valente de Matos R, Rocha J, Millett C, Santana R. Direct costs of COVID-19 inpatient admissions in a Portuguese tertiary care university centre. Portuguese Journal of Public Health. 2022 Apr 19;40(1):26-34. [DOI:10.1159/000524368]
12. Abidin Ö, Nihat A. Treatment cost of chest diseases during the COVID-19 pandemic: Case analysis at the Düzce university hospital. Tuberk Toraks. 2022;70(1):44-53. [DOI:10.5578/tt.20229906]
13. Li B, Chen L, Shi L. Determinants of hospitalization costs among moderate cases of COVID-19. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2022 Mar 3;59:00469580211059483:1-5. [DOI:10.1177/00469580211059483]
14. Solanki G, Wilkinson T, Bansal S, Shiba J, Manda S, Doherty T. COVID-19 hospitalization and mortality and hospitalization-related utilization and expenditure: Analysis of a South African private health insured population. Plos one. 2022 May 5;17(5):e0268025:1-17. [DOI:10.1371/journal.pone.0268025]
15. Aslan H, Şimşir İ, Köse E, Topaktaş G. COVID-19 costs: An example of province in Turkey. Turkish Bulletin of Hygiene and Experimental Biology. 2022 Jul 5;79(2):187-98. [DOI:10.5505/TurkHijyen.2022.17048]
16. Panneer S, Kantamaneni K, Palaniswamy U, Bhat L, Pushparaj RR, Nayar KR, Soundari Manuel H, Flower FL, Rice L. Health, economic and social development challenges of the COVID-19 pandemic: Strategies for multiple and interconnected issues. Healthcare 2022, 10, 770:1-17. [DOI:10.3390/healthcare10050770]
17. Chua KP, Conti RM, Becker NV. Trends in and factors associated with out-of-pocket spending for COVID-19 hospitalizations from March 2020 to March 2021. JAMA Network Open. 2022;5(2):e2148237:1-4. [DOI:10.1001/jamanetworkopen.2021.48237]
18. Eisenberg MD, Barry CL, Schilling CL, Kennedy-Hendricks A. Financial risk for COVID-19-like respiratory hospitalizations in consumer-directed health plans. American Journal of Preventive Medicine. 2020 Sep 1;59(3):445-8. [DOI:10.1016/j.amepre.2020.05.008]
19. Wilfong LS, Ives H, Indurlal P, Staggs S, Bock JP-D, Neubauer MA. The impact of COVID-19 on patients with cancer in the Oncology care model in the U.S. Oncology Network during performance period 8. Journal of Clinical Oncology. 2022;40(16_suppl):e18747-e:1-18. [DOI:10.1200/JCO.2022.40.16_suppl.e18747]
20. Canana N, Dula J, Manjate N, Capitine I, Mocumbi AO, Chicumbe S. The economic cost of treatment for patients with severe COVID-19 in Maputo province, Mozambique. African Journal of Health Sciences. 2022 May 18;35(1):60-9. Available at: URL: https://www.ajol.info/index.php/ajhs/article/view/225363
21. Amin A, Moon R, Agiro A, Rosenthal N, Brown H, Legg R, Pottorf W. In-hospital mortality, length of stay, and hospitalization cost of COVID-19 patients with and without hyperkalemia. The American Journal of the Medical Sciences. 2022 Oct 1;364(4):444-53. [DOI:10.1016/j.amjms.2022.04.029]
22. Abushanab D, Eldebs M, Basha A, Naseralallah L, Kazkaz H, Moursi A, Albazoon F, Wafi O, Badran S, Doi SA, Al-Maadeed S. The economic impact of optimizing a COVID-19 management protocol in pre-existing Cardiovascular disease patients. Current Problems in Cardiology. 2023 Aug 1;48(8):101177:1-20. [DOI:10.1016/j.cpcardiol.2022.101177]
23. Galdeano Lozano M, Alfaro Álvarez JC, Parra Macías N, Salas Campos R, Heili Frades S, Montserrat JM, et al. Effectiveness of intermediate respiratory care units as an alternative to intensive care units during the COVID-19 pandemic in Catalonia. International Journal of Environmental Research and Public Health. 2022, 19, 6034:1-11. [DOI:10.3390/ijerph19106034]
24. Öztaş A, Fikri Bİ, Ünsel M, Turan G. After COVID-19 infection extended intensive care process and assessment of its cost. Age. 2022;55(11.83):36-73.
https://doi.org/10.4274/csmedj.galenos.2022.2022-2-1 [DOI:10.4274/csmedj.galenos.2022.2022-2-111]
25. Scott A, Chambers R, Reimbaeva M, Atwell J, Baillon-Plot N, Draica F, Tarallo M. Real-world retrospective analysis of patient characteristics, healthcare resource utilization, costs, and treatment patterns among unvaccinated adults with COVID-19 diagnosed in outpatient settings in the United States. Journal of Medical Economics. 2022 Dec 31;25(1):287-98. [DOI:10.1080/13696998.2022.2037917]
26. Rocha-Filho CR, Martins JW, Lucchetta RC, Ramalho GS, Trevisani GF, da Rocha AP, Pinto AC, Reis FS, Ferla LJ, Mastroianni PD, Correa L. Hospitalization costs of coronaviruses diseases in upper-middle-income countries: A systematic review. PLoS ONE. 2022 Mar 11;17(3):1-13. [DOI:10.1371/journal.pone.0265003]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Site Keywords
Health, Administration, Scientific Article, Iran University of Medical Sciences,
